Hypertension is an independent risk factor for contrast nephropathy after percutaneous coronary intervention
David Conen(Yamaha (Japan)), Christian Mueller(Immutep (Germany)), Gerd Buerkle, Heinz Joachim Buettner(Universitäts-Herzzentrum Freiburg-Bad Krozingen), André P. Perruchoud(University of Bern)
Cited by 23
Related Papers
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
|European Heart Journal|2022|1.1k
State of the Art: Using Natriuretic Peptide Levels in Clinical Practice
|European Journal of Heart Failure|2008|837
Multi-ethnic genome-wide association study for atrial fibrillation
|Nature Genetics|2018|824
Prevention of Contrast Media–Associated Nephropathy
|Archives of Internal Medicine|2002|808
Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide Concentrations
|European Journal of Heart Failure|2019|786